Enzymatic Protein Modification

Enzymatic protein modification covalently alters therapeutic proteins enhancing stability or reducing immunogenicity. Pegylation conjugation with polyethylene glycol extends serum half-life. Glycosylation addition of carbohydrate chains modulates clearance. Palmitoylation hydrophobic modification enables liposomal delivery. Bond formation between proteins creates multivalent structures.

Regulatory submissions justify modification rationale. Analytical characterisation confirms modification completeness. Bioactivity assessment ensures function preservation. Immunogenicity evaluation predicts tolerability. Clinical validation confirms predicted therapeutic benefit.